Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
| Status: | Completed |
|---|---|
| Conditions: | Erectile Dysfunction, Neurology, Neurology, Endocrine |
| Therapuetic Areas: | Endocrinology, Nephrology / Urology, Neurology |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 10/5/2017 |
| Start Date: | June 2001 |
| End Date: | April 2008 |
Comparison of Anastrozole and Testosterone Versus Placebo and Testosterone Treatment of Reproductive and Sexual Dysfunction in Men With Epilepsy and Hypogonadism
The purpose of this study is to determine if treatment using a medication
(anastrozole/Arimidex), which lowers estrogen levels in the blood is better than placebo, a
tablet that does not contain any active medication, when combined with testosterone
replacement to treat reproductive and sexual dysfunction in men with epilepsy. Anastrozole,
the medication that is currently under study, does not, at this time, have FDA approval for
use for this indication.
(anastrozole/Arimidex), which lowers estrogen levels in the blood is better than placebo, a
tablet that does not contain any active medication, when combined with testosterone
replacement to treat reproductive and sexual dysfunction in men with epilepsy. Anastrozole,
the medication that is currently under study, does not, at this time, have FDA approval for
use for this indication.
This is a three-month study where baseline information is collected at the first visit and
then each patient is started on treatment with testosterone supplementation and either
anastrozole or placebo. Lab tests, seizure frequency, sexual function and mood will be
monitored on a monthly basis.
then each patient is started on treatment with testosterone supplementation and either
anastrozole or placebo. Lab tests, seizure frequency, sexual function and mood will be
monitored on a monthly basis.
Inclusion Criteria:
- Subject must be a male between the ages of 18 and 50 years.
- Subject must have localization-related epilepsy with complex partial and/or secondary
generalized seizures.
- Subject will meet criteria for hypogonadism (abnormally low bioactive testosterone
levels and abnormally low scores on questionnaires of reproductive and sexual
function).
- Subject will have had a normal urogenital and rectal/prostate exam during the year
prior to entry.
- Subject will have had documentation of therapeutic range serum AED levels, a normal
CBC, and hepatic enzyme (ALT,AST, alkaline phosphatase) levels that are less than
twofold elevated during the 6 months prior to entry.
Exclusion Criteria:
- Subject that has taken hormones, major tranquilizers or antidepressants in the three
months prior to entry.
We found this trial at
1
site
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
Click here to add this to my saved trials
